Reproductive Options in NF1, NF2, and Schwannomatosis (Revised Article)
People who themselves have been diagnosed with NF1, NF2 and Schwannomatosis, or who have a child with one of these…
Read More
People who themselves have been diagnosed with NF1, NF2 and Schwannomatosis, or who have a child with one of these…
Read More
Velopharyngeal insufficiency (VPI) is a resonance disorder that occurs during speech that results from the inability of the vellum (or…
Read More
Due to the pandemic there will be NO NF Midwest Symposium and iNFo Fair this year. We may present short…
Read More
KOSELUGO FAQS In April 2020 the U.S. Food and Drug Administration (FDA) approved KOSELUGOTM (selumetinib) for use in children over…
Read More
We want you to know that we are working from home to do anything we can to continue to support you…
Read More
NF Midwest has had a very important article written about Malignant Peripheral Nerve Sheath Tumors (or MPNSTs) in Neurofibromatosis Type…
Read More
Dr. James Tonsgard, MD, of the University of Chicago, graciously contributed this article. The article is an overview of Gastrointestinal…
Read More
If you’re a post high school student with neurofibromatosis or schwannomatosis, and you live in NF Midwest’s service region of…
Read More
An interesting article was just published in the Journal of Paediatric and Child Health called “Perceived fatigue in children and…
Read More
At NF Midwest’s Symposium and iNFo Fair last Saturday, November 9th, we were very fortunate to have Dr. Lu Le…
Read More
© 2026 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.